Research trends in glioma chemoradiotherapy resistance: a bibliometric analysis (2003–2023)
BackgroundGlioma is the most aggressive primary malignant tumor of the central nervous system, characterized by high recurrence rates and resistance to chemoradiotherapy, making therapeutic resistance a major challenge in neuro-oncology. Recent research emphasizes the role of the tumor microenvironm...
Saved in:
Main Authors: | Shishi Yu, Jinya Wu, Yuan Jing, Ping Lin, Lang Lang, Yifan Xiong, Wangzhong Chen, Wenhua Liu, Changpeng Sun, Yuntao Lu |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2025-02-01
|
Series: | Frontiers in Oncology |
Subjects: | |
Online Access: | https://www.frontiersin.org/articles/10.3389/fonc.2025.1539937/full |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Integrative analysis of immunogenic PANoptosis and experimental validation of cinobufagin-induced activation to enhance glioma immunotherapy
by: Yonghua Cai, et al.
Published: (2025-02-01) -
Hormone Receptors in Cervicovaginal Cells
by: Şayeste Demirezen, et al.
Published: (2013-04-01) -
Effect of chemoradiotherapy on the dynamics of circulating lymphocyte subsets in patients with non-metastatic nasopharyngeal carcinoma
by: Lilan Yi, et al.
Published: (2025-02-01) -
Phase II clinical trial assessing the addition of hyperthermia to salvage concurrent chemoradiotherapy for unresectable recurrent head and neck cancer in previously irradiated patients
by: Kai-Lin Yang, et al.
Published: (2025-02-01) -
Effect of primary tumor volume on survival of concurrent chemoradiotherapy in stage IV non‐small cell lung cancer
by: Xiaxia Chen, et al.
Published: (2024-09-01)